Skip to content

FIRE Stones : Impact of Furosemide on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser : a controlled two-parallel group multicenter trial with blinding evaluation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502890-40-00
Acronym
DR220258
Enrollment
374
Registered
2023-09-27
Start date
2024-01-04
Completion date
Unknown
Last updated
2025-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Destruction of kidney stones

Brief summary

Stone-free rate at 3 months of a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results

Detailed description

Post-operative urinary tract infection will be assessed within 30 days after surgery on the combination of: - Fever higher than 38.5°C and/or, - Chills and/or, - Clinical symptoms (supra-pubic pain, dysuria, pollakiuria, urgency, urinary burning, back pain radiating to the genitals, hematuria) and/or - Positive urine culture with a significant bacteriuria threshold., Post-operative pain will be assessed using a numerical pain scale ranging from 0 to 10 in the recovery room, in the service and at the discharge., Furosemide adverse events will be assessed., Effect of the prescription of an alpha-blocker will be looked at considering the primary outcome, Evaluation of agreement between the imaging analysis of the urologist and the specialized radiologist will be looked at considering the primary outcome. Urologists will assess CT-Scan while the study is going on while specialized radiologists will assess the CT Scan at the end of the study.

Interventions

DRUGFUROSEMIDE

Sponsors

Centre Hospitalier Regional Universitaire De Tours
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Stone-free rate at 3 months of a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results

Secondary

MeasureTime frame
Post-operative urinary tract infection will be assessed within 30 days after surgery on the combination of: - Fever higher than 38.5°C and/or, - Chills and/or, - Clinical symptoms (supra-pubic pain, dysuria, pollakiuria, urgency, urinary burning, back pain radiating to the genitals, hematuria) and/or - Positive urine culture with a significant bacteriuria threshold., Post-operative pain will be assessed using a numerical pain scale ranging from 0 to 10 in the recovery room, in the service and at the discharge., Furosemide adverse events will be assessed., Effect of the prescription of an alpha-blocker will be looked at considering the primary outcome, Evaluation of agreement between the imaging analysis of the urologist and the specialized radiologist will be looked at considering the primary outcome. Urologists will assess CT-Scan while the study is going on while specialized radiologists will assess the CT Scan at the end of the study.

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 7, 2026